http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2164688-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e58b17ef730ad6201fc70d095b88e907 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3368235b8b9d7db90aeeb7776cefd27c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2000-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2001-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1cce1be8be170e620c1eccc5b8738b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_320883d1c727a76bccfd36cc152e8a0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c98c1ecaa4c8f8501fbce9a895bc17e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b59429613d2f30013cf5acc33725f0a |
| publicationDate | 2001-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2164688-C1 |
| titleOfInvention | Method for evaluating epilepsy pharmacotherapy effectiveness |
| abstract | FIELD: medicine. SUBSTANCE: method involves determining contents of autoantibodies to quiscavalate-binding membrane protein in patient blood in addition to electroencephalographic monitoring. The measurements are performed by means of paroxysmal activity test before pharmacotherapy and every 15-20 days in dynamic mode. Contents of autoantibodies to quiscavalate-binding membrane protein being reduced at least by 10 conditional units in every following test, the pharmacotherapy is considered as effective one. EFFECT: increased objectivity of evaluation. 2 dwg |
| priorityDate | 2000-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.